advertisement
JAMA ophthalmology 83
Showing records 1 to 25 | Display all abstracts in JAMA ophthalmology94932 Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma
E JY
JAMA ophthalmology 2021; 139: 1053-1060
95476 Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020
Berkowitz ST
JAMA ophthalmology 2021; 139: 629-637
94728 Association of the MYOC p.(Gln368Ter) Variant With Glaucoma in a Finnish Population
Liuska PJ
JAMA ophthalmology 2021; 139: 762-768
95341 Visual Outcomes and Complications After Lensectomy for Traumatic Cataract in Children
JAMA ophthalmology 2021; 139: 647-653
94717 Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment
Fenwick EK
JAMA ophthalmology 2021; 139: 866-874
95521 Refractive Outcomes After Immediate Sequential vs Delayed Sequential Bilateral Cataract Surgery
Owen JP
JAMA ophthalmology 2021; 139: 876-885
95519 A Global Assessment of Eye Health and Quality of Life: A Systematic Review of Systematic Reviews
Assi L
JAMA ophthalmology 2021; 139: 526-541
94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Proudfoot JA
JAMA ophthalmology 2021; 139: 839-846
95521 Refractive Outcomes After Immediate Sequential vs Delayed Sequential Bilateral Cataract Surgery
Blazes M; Blazes M
JAMA ophthalmology 2021; 139: 876-885
95519 A Global Assessment of Eye Health and Quality of Life: A Systematic Review of Systematic Reviews
Chamseddine F
JAMA ophthalmology 2021; 139: 526-541
95476 Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020
Groth SL
JAMA ophthalmology 2021; 139: 629-637
94728 Association of the MYOC p.(Gln368Ter) Variant With Glaucoma in a Finnish Population
Lemmelä S
JAMA ophthalmology 2021; 139: 762-768
94932 Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma
Mihailovic A
JAMA ophthalmology 2021; 139: 1053-1060
94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Zangwill LM
JAMA ophthalmology 2021; 139: 839-846
95341 Visual Outcomes and Complications After Lensectomy for Traumatic Cataract in Children
Bothun ED
JAMA ophthalmology 2021; 139: 647-653
94717 Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment
Ozdemir S
JAMA ophthalmology 2021; 139: 866-874
95519 A Global Assessment of Eye Health and Quality of Life: A Systematic Review of Systematic Reviews
Ibrahim P
JAMA ophthalmology 2021; 139: 526-541
95341 Visual Outcomes and Complications After Lensectomy for Traumatic Cataract in Children
Repka MX
JAMA ophthalmology 2021; 139: 647-653
94728 Association of the MYOC p.(Gln368Ter) Variant With Glaucoma in a Finnish Population
Havulinna AS
JAMA ophthalmology 2021; 139: 762-768
94841 Estimated Utility of the Short-term Assessment of Glaucoma Progression Model in Clinical Practice
Moghimi S
JAMA ophthalmology 2021; 139: 839-846
95521 Refractive Outcomes After Immediate Sequential vs Delayed Sequential Bilateral Cataract Surgery
Lacy M
JAMA ophthalmology 2021; 139: 876-885
94717 Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment
Man REK
JAMA ophthalmology 2021; 139: 866-874
94932 Association Between Visual Field Damage and Gait Dysfunction in Patients With Glaucoma
Garzon C
JAMA ophthalmology 2021; 139: 1053-1060
95476 Racial/Ethnic Disparities in Ophthalmology Clinical Trials Resulting in US Food and Drug Administration Drug Approvals From 2000 to 2020
Gangaputra S
JAMA ophthalmology 2021; 139: 629-637
94717 Development and Validation of a Preference-Based Glaucoma Utility Instrument Using Discrete Choice Experiment
Baid D
JAMA ophthalmology 2021; 139: 866-874
